Sengenics Company
Functional Proteomics company focused on leveraging its KREX™ protein folding technology in the identification of novel biomarkers
Technology:
Biomarkers
Industry:
Omic
Headquarters:
Singapore, Central Region, Singapore
Founded Date:
1996-01-01
Employees Number:
101-250
Funding Status:
M&A
Investors Number:
1
Estimated Revenue:
$1M to $10M
Last Funding Date:
2019-11-26
Last Funding Type:
Grant
Register and Claim Ownership